WAY-311677

CAS No. 19948-85-7

WAY-311677( —— )

Catalog No. M28996 CAS No. 19948-85-7

WAY-311677 has potential antiproliferative activity and is a FAK inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 30 In Stock
10MG 53 In Stock
25MG 113 In Stock
50MG 178 In Stock
100MG 262 In Stock
200MG 373 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WAY-311677
  • Note
    Research use only, not for human use.
  • Brief Description
    WAY-311677 has potential antiproliferative activity and is a FAK inhibitor.
  • Description
    WAY-311677 has potential antiproliferative activity and is a FAK inhibitor.
  • In Vitro
    FAK-IN-7 (0-10 μM; 48 h) inhibits MCF-7 and B16-F10 cells proliferation.Cell Proliferation Assay Cell Line:MCF-7 and B16-F10 cells Concentration:0-10 μM Incubation Time:48 h Result:Exhibited anti-proliferative activity against MCF-7 and B16-F10 cells with IC50 values of 3.57 and 3.52 μM, respectively.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    FAK
  • Recptor
    FAK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    19948-85-7
  • Formula Weight
    295.36
  • Molecular Formula
    C16H13N3OS
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 10 mg/mL (33.86 mM)
  • SMILES
    O=C(C1=CC=CC=C1)NC2=NN=C(C3=CC=C(C)C=C3)S2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • GSK-2256098

    GSK-2256098 (GTPL-7939) is a potent, selective, reversible and ATP-competitive inhibitor of FAK kinase with Ki of 0.4 nM.

  • Y15

    Y15 is a potent and specificsmall-molecule FAK scaffolding inhibitor that inhibits its autophosphorylation activity blocks tumor growth.

  • Tasimelteon

    Tasimelteon is a melatonin receptor agonist that is used for the treatment of non-24 hour sleep-wake disorder in blind individuals.